tiprankstipranks
Trending News
More News >
Rennova Health (RNVA)
OTHER OTC:RNVA
US Market

Rennova Health (RNVA) Ratios

Compare
224 Followers

Rennova Health Ratios

RNVA's free cash flow for Q4 2023 was $0.48. For the 2023 fiscal year, RNVA's free cash flow was decreased by $ and operating cash flow was $-0.56. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.13 0.13 0.10 0.05 0.06
Quick Ratio
0.12 0.12 0.10 0.04 0.06
Cash Ratio
0.01 0.01 0.02 <0.01 <0.01
Solvency Ratio
-0.06 -0.06 -0.25 -0.28 -0.65
Operating Cash Flow Ratio
>-0.01 >-0.01 -0.19 -0.28 -0.16
Short-Term Operating Cash Flow Coverage
-0.02 -0.02 -0.59 -0.86 -0.28
Net Current Asset Value
$ -43.30M$ -43.30M$ -42.22M$ -58.56M$ -85.88M
Leverage Ratios
Debt-to-Assets Ratio
0.75 0.75 0.82 1.80 3.43
Debt-to-Equity Ratio
-0.53 -0.53 -0.59 -0.45 -0.66
Debt-to-Capital Ratio
-1.11 -1.11 -1.43 -0.82 -1.93
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 -0.03 0.00
Financial Leverage Ratio
-0.71 -0.71 -0.72 -0.25 -0.19
Debt Service Coverage Ratio
-0.03 -0.03 -0.06 -0.24 -0.53
Interest Coverage Ratio
-0.62 -0.62 -1.65 -1.75 -0.75
Debt to Market Cap
1.45K 1.45K 273.85K 5.31M 877.42K
Interest Debt Per Share
<0.01 <0.01 35.09 106.66M 1.29B
Net Debt to EBITDA
-63.16 -63.16 -12.14 -2.62 -2.09
Profitability Margins
Gross Profit Margin
48.08%48.08%-64.16%-63.66%7.14%
EBIT Margin
-5.40%-5.40%-59.15%-126.54%-155.46%
EBITDA Margin
-1.80%-1.80%-39.19%-116.81%-150.48%
Operating Profit Margin
-10.81%-10.81%-163.54%-238.82%-102.15%
Pretax Profit Margin
-22.72%-22.72%-388.37%-263.22%-295.59%
Net Profit Margin
-25.26%-25.26%-382.80%-245.05%-377.96%
Continuous Operations Profit Margin
-25.12%-25.12%-163.54%-245.05%-291.38%
Net Income Per EBT
111.19%111.19%98.57%93.10%127.86%
EBT Per EBIT
210.12%210.12%237.47%110.22%289.37%
Return on Assets (ROA)
-16.01%-16.01%-62.85%-143.89%-410.83%
Return on Equity (ROE)
11.32%11.32%45.20%35.99%78.96%
Return on Capital Employed (ROCE)
4.91%4.91%19.73%36.65%23.77%
Return on Invested Capital (ROIC)
11.14%11.14%46.22%59.47%112.57%
Return on Tangible Assets
-16.21%-16.21%-63.69%-147.00%-425.57%
Earnings Yield
-32956.13%-32956.13%-22504579.88%-450868635.31%-108174240.97%
Efficiency Ratios
Receivables Turnover
2.41 2.41 0.90 3.75 3.80
Payables Turnover
0.59 0.59 0.44 0.83 1.16
Inventory Turnover
27.89 27.89 18.87 26.46 24.16
Fixed Asset Turnover
2.73 2.73 0.59 0.82 1.88
Asset Turnover
0.63 0.63 0.16 0.59 1.09
Working Capital Turnover Ratio
-0.31 -0.31 -0.07 -0.11 -0.27
Cash Conversion Cycle
-456.54 -456.54 -410.79 -330.34 -203.78
Days of Sales Outstanding
151.35 151.35 406.79 97.32 96.07
Days of Inventory Outstanding
13.09 13.09 19.35 13.80 15.10
Days of Payables Outstanding
620.98 620.98 836.92 441.46 314.95
Operating Cycle
164.44 164.44 426.13 111.11 111.18
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 -16.25 -56.21M -242.79M
Free Cash Flow Per Share
>-0.01 >-0.01 -16.25 -57.17M -242.79M
CapEx Per Share
<0.01 <0.01 0.00 967.08K 2.27K
Free Cash Flow to Operating Cash Flow
1.16 1.16 1.00 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
-6.20 -6.20 0.00 -58.12 -106.78K
Capital Expenditure Coverage Ratio
-6.20 -6.20 0.00 -58.12 -106.78K
Operating Cash Flow Coverage Ratio
-0.01 -0.01 -0.56 -0.76 -0.27
Operating Cash Flow to Sales Ratio
-0.02 -0.02 -2.76 -2.33 -0.85
Free Cash Flow Yield
-2537.75%-2537.75%-16252837.01%-436448776.69%-24278944.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Price-to-Sales (P/S) Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Price-to-Book (P/B) Ratio
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
-0.04 -0.04 >-0.01 >-0.01 >-0.01
Price-to-Operating Cash Flow Ratio
-0.05 -0.05 >-0.01 >-0.01 >-0.01
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Enterprise Value Multiple
-63.20 -63.20 -12.14 -2.62 -2.09
Enterprise Value
14.84M 14.84M 15.33M 22.00M 50.39M
EV to EBITDA
-63.20 -63.20 -12.14 -2.62 -2.09
EV to Sales
1.14 1.14 4.76 3.05 3.15
EV to Free Cash Flow
-58.52 -58.52 -1.72 -1.29 -3.72
EV to Operating Cash Flow
-67.96 -67.96 -1.72 -1.31 -3.72
Tangible Book Value Per Share
>-0.01 >-0.01 -50.26 -164.96M -1.38B
Shareholders’ Equity Per Share
>-0.01 >-0.01 -49.79 -164.09M -1.37B
Tax and Other Ratios
Effective Tax Rate
-0.11 -0.11 0.01 0.07 -0.28
Revenue Per Share
<0.01 <0.01 5.88 24.10M 286.21M
Net Income Per Share
>-0.01 >-0.01 -22.50 -59.06M -1.08B
Tax Burden
1.11 1.11 0.99 0.93 1.28
Interest Burden
4.21 4.21 6.57 2.08 1.90
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.53 0.53 2.33 1.62 1.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 >-0.01
Income Quality
0.07 0.07 1.69 0.95 0.29
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis